Revascularization strategies for patients with myocardial infarction and multi-vessel disease: A critical appraisal of the current evidence

被引：0

作者：

Muhammad O Zaman ^{[1
]}

Mohammad K Mojadidi ^{[2
]}

Islam Y Elgendy ^{[3
]}

机构：

[1] Division of Cardiovascular Medicine, Department of Medicine, University of Florida College of Medicine

[2] Division of Cardiovascular Medicine, Department of Medicine, Virginia Commonwealth University

[3] Division of Cardiovascular Medicine, Massachusetts General Hospital and Harvard Medical School

来源：

Journal of Geriatric Cardiology | 2019年 / 16 卷 / 09期

关键词：

Coronary artery disease; Mortality; Myocardial Infarction; Percutaneous coronary intervention;

D O I：

暂无

中图分类号：

R542.22 [];

学科分类号：

1002 ; 100201 ;

摘要：

Approximately half of patients presenting with myocardial infarction are found to have non-infarct related multi-vessel severe coronary artery disease. Various observational studies and randomized controlled trials have been conducted to assess if revascularization of non-infarct related artery is associated with better clinical outcomes. In this review, the authors discuss the various revascularization strategies in patients with multi-vessel disease who present with myocardial infarction.

引用

页码：717 / 723

页数：7

共 20 条

[1] Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes
Rathod, Krishnaraj S.
Koganti, Sudheer
Jain, Ajay K.
Astroulakis, Zoe
Lim, Pitt
Rakhit, Roby
Kalra, Sundeep Singh
Dalby, Miles C.
O'Mahony, Constantinos
Malik, Iqbal S.
Knight, Charles J.
Mathur, Anthony
Redwood, Simon
Sirker, Alexander
MacCarthy, Philip A.
Smith, Elliot J.
Wragg, Andrew
Jones, Daniel A.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (17) : 1989 - 1999
[2] Complete or Culprit-Only Revascularization for PatientsWith Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Elgendy, Islam Y.
Mahmoud, Ahmed N.
Kumbhani, Dharam J.
Bhatt, Deepak L.
Bavry, Anthony A.
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (04) : 315 - 324
[3] Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial[J] . Thomas Engstr?m,Henning Kelb?k,Steffen Helqvist,Dan Eik H?fsten,Lene Kl?vgaard,Lene Holmvang,Erik J?rgensen,Frants Pedersen,Kari Saunam?ki,Peter Clemmensen,Ole De Backer,Jan Ravkilde,Hans-Henrik Tilsted,Anton Boel Villadsen,Jens Aar?e,Svend Eggert Jensen,Bent Raungaard,Lars K
[4] Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease
Gershlick, Anthony H.
Khan, Jamal Nasir
Kelly, Damian J.
Greenwood, John P.
Sasikaran, Thiagarajah
Curzen, Nick
Blackman, Daniel J.
Dalby, Miles
Fairbrother, Kathryn L.
Banya, Winston
Wang, Duolao
Flather, Marcus
Hetherington, Simon L.
Kelion, Andrew D.
Talwar, Suneel
Gunning, Mark
Hall, Roger
Swanton, Howard
McCann, Gerry P.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : 963 - 972
[5] Long‐term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit‐only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry[J] . Antonio Manari,Elisabetta Varani,Paolo Guastaroba,Mila Menozzi,Marco Valgimigli,Alberto Menozzi,Paolo Magnavacchi,Nicoletta Franco,Antonio Marzocchi,Gianni Casella.Cathet. Cardiovasc. Intervent. . 2014 (6)
[6] Culprit Vessel Versus Multivessel Intervention at the Time of Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction and Multivessel Disease: Real-World Analysis of 3984 Patients in London[J] . M. Bilal Iqbal,Charles Ilsley,Tito Kabir,Robert Smith,Rebecca Lane,Mark Mason,Piers Clifford,Tom Crake,Sam Firoozi,Sundeep Kalra,Charles Knight,Pitt Lim,Iqbal S. Malik,Anthony Mathur,Pascal Meier,Roby D. Rakhit,Simon Redwood,Mark Whitbread,Dan Bromage,Krishn
[7] Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction[J] . Raban Jeger,Milosz Jaguszewski,Brahmajee N. Nallamothu,Thomas F. Lüscher,Philip Urban,Giovanni B. Pedrazzini,Paul Erne,Dragana Radovanovic.International Journal of Cardiology . 2014 (1)
[8] Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease[J] . Min Chul Kim,Myung Ho Jeong,Keun Ho Park,Doo Sun Sim,Nam Sik Yoon,Hyun Joo Yoon,Kye Hun Kim,Young Joon Hong,Hyung Wook Park,Ju Han Kim,Youngkeun Ahn,Jeong Gwan Cho,Jong Chun Park.International Journal of Cardiology . 2014 (2)
[9] Percutaneous Coronary Intervention Should Be Guided by Fractional Flow Reserve Measurement[J] . William F. Fearon.Circulation . 2014 (18)
[10] Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: Analysis of over 4.400 patients in the EHS-PCI registry[J] . Timm Bauer,Uwe Zeymer,Matthias Hochadel,Helge M?llmann,Franz Weidinger,Ralf Zahn,Holger M. Nef,Christian W. Hamm,Jean Marco,Anselm K. Gitt.International Journal of Cardiology . 2013 (3)

← 1 2 →